Breaking News Instant updates and real-time market news.

APO

Apollo Global

$34.27

0.67 (1.99%)

, OMF

OneMain Holdings

$26.64

0.34 (1.29%)

06:31
01/04/18
01/04
06:31
01/04/18
06:31

Apollo Global led group to acquire significant position in OneMain Holdings

APO

Apollo Global

$34.27

0.67 (1.99%)

OMF

OneMain Holdings

$26.64

0.34 (1.29%)

  • 10

    Jan

  • 11

    Jan

APO Apollo Global
$34.27

0.67 (1.99%)

12/11/17
SBSH
12/11/17
NO CHANGE
SBSH
Citi sees potential sale of Voya assets as win for three companies
Citi analyst Suneet Kamath says Voya Financial's (VOYA) potential sale of $50B in annuity assets to Apollo Global (APO) could be a win for both companies along with Athene Holding (ATH). Considering the relationship between Apollo and Athene, any transfer of general account assets from Voya to Apollo would eventually be housed in Athene, Kamath tells investors in a research note. He estimates a Voya annuity deal could add at least $2 to his Apollo price target. The analyst continues to see more upside in Apollo than Athene.
01/03/18
MSCO
01/03/18
UPGRADE
MSCO
Overweight
Apollo Global upgraded to Overweight from Equal Weight at Morgan Stanley
01/03/18
MSCO
01/03/18
UPGRADE
Target $62
MSCO
Equal Weight
LPL Financial upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley analyst Michael Cyprys raised his 2018 and 2019 EPS estimates by 25% and 20%, respectively, for discount brokers and 17% and 16%, respectively, for traditional asset managers, after updating for stronger equity markets, the latest forward curve and tax cuts. Given this context, he upgraded LPL Financial to Equal Weight from Underweight, stating that he views it as a key beneficiary of tax reform, rising short-term interest rates and strong equity markets. Cyprys increased his price target on LPL shares to $62 from $45. He also upgraded Apollo Global (APO) and E-Trade (ETFC), each to Overweight from Equal Weight.
01/03/18
MSCO
01/03/18
UPGRADE
Target $42
MSCO
Overweight
Apollo Global upgraded to Overweight at Morgan Stanley
As previously reported, Morgan Stanley analyst Michael Cyprys upgraded Apollo Global to Overweight from Equal Weight, noting that the company is entering its portfolio harvesting stage and he has become more bullish on its growth prospects with the credit business scaling faster. For Apollo, and other alternative asset managers, he also assumes lower tax rates and a higher multiple on fee-related earnings. Cyprys increased his price target on Apollo shares to $42 from $32.
OMF OneMain Holdings
$26.64

0.34 (1.29%)

11/03/17
COMP
11/03/17
DOWNGRADE
COMP
Neutral
OneMain Holdings downgraded to Neutral from Buy at Compass Point
11/08/17
BOFA
11/08/17
DOWNGRADE
Target $30
BOFA
Neutral
OneMain Holdings downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Kenneth Bruce downgraded OneMain Holding to Neutral and cut its price target to $30 from $35 following the strategic review and decision to pursue its previously announced strategy and the announced 10M share secondary offering by Fortress-affiliated funds. The analyst said the additional shares are 20% of the float and sees further downside as the news and shares are digested by investors.
11/08/17
JANY
11/08/17
NO CHANGE
Target $28
JANY
Neutral
OneMain Holdings 10-Q seems to end takeover speculation, says Janney Capital
Janney Capital analyst John Rowan noted that several media reports emerged in October that OneMain Holdings was up for sale, but the company's 10-Q contained "two inconspicuous sentences" that appeared to end that speculation, as OneMain stated that it "recently completed an evaluation of certain alternatives to maximize stockholder value, including a sale of its business. The evaluation has concluded and the company continues to implement its previously disclosed strategies." Since he had not adjusted his valuation of OneMain based on any takeover scenario, Rowan keeps a Neutral rating and $28 fair value estimate on the shares following the disclosure.
12/12/17
FBCO
12/12/17
NO CHANGE
FBCO
Outperform
Synchrony, Discover among biggest beneficiaries of tax reform, says Credit Suisse
Credit Suisse analyst Moshe Orenbuch views tax reform as highly beneficial to U.S. consumer finance companies as most companies are full U.S. tax payers and any increases in consumer confidence from more cash flow could lead to more consumer borrowing, driving faster revenue growth and improved credit quality. His favorites to benefit from tax reform are Synchrony (SYF), Discover (DFS), OneMain (OMF), CIT Group (CIT), Santander Consumer (SC), Sallie Mae (SLM), and Air Lease (AL).

TODAY'S FREE FLY STORIES

WELL

Welltower

$50.45

-0.57 (-1.12%)

, QCP

Quality Care Properties

$22.72

1.92 (9.23%)

05:25
04/26/18
04/26
05:25
04/26/18
05:25
Hot Stocks
Breaking Hot Stocks news story on Welltower, Quality Care Properties »

Welltower to acquire…

WELL

Welltower

$50.45

-0.57 (-1.12%)

QCP

Quality Care Properties

$22.72

1.92 (9.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

  • 04

    May

ANTM

Anthem

$238.81

13.73 (6.10%)

05:22
04/26/18
04/26
05:22
04/26/18
05:22
Upgrade
Anthem rating change  »

Anthem upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$159.69

0.03 (0.02%)

05:20
04/26/18
04/26
05:20
04/26/18
05:20
Recommendations
Facebook analyst commentary  »

Facebook price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERN

Erin Energy

$1.65

-0.825 (-33.33%)

05:18
04/26/18
04/26
05:18
04/26/18
05:18
Hot Stocks
Erin Energy files voluntary petitions under Chapter 11 to pursue reorganization »

Erin Energy and certain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXS

Citrix

$96.54

0.04 (0.04%)

05:16
04/26/18
04/26
05:16
04/26/18
05:16
Recommendations
Citrix analyst commentary  »

Citrix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 08

    May

  • 09

    May

AMD

AMD

$9.72

-0.37 (-3.67%)

05:13
04/26/18
04/26
05:13
04/26/18
05:13
Recommendations
AMD analyst commentary  »

AMD could see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

EBAY

eBay

$40.98

-0.2 (-0.49%)

05:09
04/26/18
04/26
05:09
04/26/18
05:09
Recommendations
eBay analyst commentary  »

eBay GMV growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVG

Trivago

$4.71

-1.65 (-25.94%)

05:01
04/26/18
04/26
05:01
04/26/18
05:01
Downgrade
Trivago rating change  »

Trivago downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPR

HighPoint Resources

$6.65

0.14 (2.15%)

04:58
04/26/18
04/26
04:58
04/26/18
04:58
Initiation
HighPoint Resources initiated  »

HighPoint Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

AVY

Avery Dennison

$106.68

1.195 (1.13%)

04:57
04/26/18
04/26
04:57
04/26/18
04:57
Upgrade
Avery Dennison rating change  »

Avery Dennison upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 4/21 Jobless…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/25 Fed Balance…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Durable Goods Orders to be reported at 08:30 »

March Durable Goods…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Durable Goods Orders Ex-transportation to be reported at 08:30 »

March Durable Goods…

WYN

Wyndham

$117.67

1.83 (1.58%)

, LQ

La Quinta

$19.70

0.08 (0.41%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
La Quinta to host special shareholder meeting »

Special Shareholder…

WYN

Wyndham

$117.67

1.83 (1.58%)

LQ

La Quinta

$19.70

0.08 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 02

    May

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Wholesale Inventories [Advance] M/M % hange to be reported at 08:30 »

March Wholesale…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
International Trade in Goods Balance to be reported at 08:30 »

March International Trade…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/16 Money Supply…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/20 EIA Natural…

SMMT

Summit Therapeutics

$13.66

0.13 (0.96%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Summit Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

ABBV

AbbVie

$91.91

0.57 (0.62%)

, ACOR

Acorda Therapeutics

$22.95

-0.15 (-0.65%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
American Academy of Neurology to hold annual meeting »

2018 Annual Meeting of…

ABBV

AbbVie

$91.91

0.57 (0.62%)

ACOR

Acorda Therapeutics

$22.95

-0.15 (-0.65%)

ALXN

Alexion

$106.07

-0.37 (-0.35%)

AKCA

Akcea Therapeutics

$26.85

0.02 (0.07%)

RHHBY

Roche

TEVA

Teva

$17.27

-0.28 (-1.60%)

UBS

UBS

$16.78

-0.095 (-0.56%)

MDT

Medtronic

$79.47

0.12 (0.15%)

MCK

McKesson

$151.70

2.76 (1.85%)

NVTA

Invitae

$5.53

-0.15 (-2.64%)

IONS

Ionis Pharmaceuticals

$43.98

-1.35 (-2.98%)

IPXL

Impax

$19.25

-0.65 (-3.27%)

DNA

Bought by RHHBY

DGX

Quest Diagnostics

$101.17

1.42 (1.42%)

ESALY

Eisai

DEPO

Depomed

$6.66

-0.17 (-2.49%)

CPRX

Catalyst Pharmaceuticals

$2.64

0.04 (1.54%)

BSX

Boston Scientific

$29.44

1.01 (3.55%)

BMRN

BioMarin

$81.41

0.33 (0.41%)

MYL

Mylan

$38.93

-1.32 (-3.28%)

NBIX

Neurocrine

$78.13

-0.3 (-0.38%)

NVS

Novartis

$76.42

-0.58 (-0.75%)

PFE

Pfizer

$36.69

-0.36 (-0.97%)

RARX

RA Pharmaceuticals

$5.76

-0.2 (-3.36%)

SNY

Sanofi

$40.11

0.335 (0.84%)

SYK

Stryker

$165.44

0.77 (0.47%)

SUPN

Supernus

$47.30

0.55 (1.18%)

LLY

Eli Lilly

$81.17

1.08 (1.35%)

BAYRY

Bayer

AMGN

Amgen

$174.83

2.92 (1.70%)

ALNY

Alnylam

$94.35

-0.34 (-0.36%)

BIIB

Biogen

$269.47

7.45 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 28

    May

  • 30

    May

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 16

    Jun

  • 06

    Jul

  • 11

    Aug

  • 12

    Sep

  • 05

    Oct

  • 20

    Oct

  • 13

    Nov

  • 28

    Jan

SCPH

scPharmaceuticals

$9.92

-0.1 (-1.00%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
scPharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 23

    Jun

ALNA

Allena Pharmaceuticals

$14.77

0.845 (6.07%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Allena Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

RIO

Rio Tinto

$55.24

-0.44 (-0.79%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Rio Tinto management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.